Rafarma Pharmaceuticals, Inc.

OTC
RAFA
paper.types.company
Rentabilité sur six mois: +4.6%
Rendement en dividendes: 0%
Secteur: Healthcare

0.091 $

-0.012 $ -11.65%
0.033 $
0.178 $

paper.min_max_per_year

Calendrier des promotions Rafarma Pharmaceuticals, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Rafarma Pharmaceuticals, Inc.

Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd.

plus de détails
to research and manufacture the first medical cannabis suppositories for patients suffering from inflammatory bowel disease. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company is based in Sandy, Utah with a manufacturing and distribution facility in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

ISIN
US75062C1009
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 1.73 8
P/BV 1.68 8
P/E 64.3 1
Efficacité
Nom Signification Grade
ROA 2.25 1
ROE 2.61 1
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA 0 10
Debt/Ratio 0 10
Debt/Equity 0.1576 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % -11.1 0
Rentabilité Ebitda, % -90.22 0
Rentabilité EPS, % -90.52 0
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 0.103 $ 0 $ 0 $ -11.65 % 0 % 0 %
common.calendar.number_days.7d 0.111 $ 0 $ 0 $ -18.02 % 0 % 0 %
common.calendar.number_days.30d 0.086 $ 0.091 $ 0.15 $ 5.81 % 0 % 0 %
common.calendar.number_days.90d 0.166 $ 0.071 $ 0.175 $ -45.18 % 0 % 0 %
common.calendar.number_days.180d 0.087 $ 0.061 $ 0.178 $ 4.6 % 0 % 0 %
common.calendar.number_days.1y 0.093 $ 0.033 $ 0.178 $ -2.15 % 0 % 0 %
common.calendar.number_days.3y 0.578 $ 0.033 $ 0.71 $ -84.26 % 0 % 0 %
common.calendar.number_days.5y 0.368 $ 0.033 $ 3.07 $ -75.27 % 0 % 0 %
common.calendar.number_days.10y 0 $ 0.002 $ 3.07 $ 0 % 0 % 0 %
common.calendar.number_days.ytd 0.075 $ 0.071 $ 0.178 $ 21.33 % 0 % 0 %

Entreprises similaires

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Sergey Brusnitsin J.D., Ph.D. Chief Financial Officer and Director N/A
Mr. Anucha Phetpheng Executive Vice-President for Thai Operations N/A 1965 (60 années)
Mr. Alexander Ageev Esq. Secretary, Treasurer and Director N/A

Informations sur l'entreprise

Adresse: United States, Sandy. UT, 49 West 9000 South - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://rafarma.si